The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision medicine means moving healthcare from a one-size-fits-all approach to a more targeted approach, where decisions are informed by each individual’s unique clinical, molecular, and lifestyle information. Working closely together with the precision medicine community, Thermo Fisher Scientific is helping advance this revolution in diagnosis and treatment. We leverage our global infrastructure and expertise to provide industry-leading capabilities, from population profiling to targeted therapeutics.
Explore our precision medicine offerings.
We often hear about the impact that precision medicine will have on healthcare systems and how we personally manage our health. But what about those tasked with bringing precision medicine tests and treatments to the market? What are they doing, what challenges do they face, and how are they working with stakeholders within the wider healthcare ecosystem? Learn more about industry approaches in this report by Newsweek Vantage and sponsored by Bristol-Myers Squibb, Medidata and Thermo Fisher Scientific.
Mainstream news headlines tout groundbreaking changes in how we treat cancer, but too few patients outside of the larger medical research centers have access to this level of care. How are leaders in the health care and life sciences industries working to cost-effectively deliver precision medicine to the masses within the next decade?
Precision oncology using next-generation sequencing (NGS) accelerates targeted therapy treatment selection and improves patient outcomes. NGS is involved throughout the development continuum for targeted treatments – from translational research to companion diagnostics testing. Here, we share stories of how NGS technology has enabled personalized oncology to improve patient outcomes.
for Broad-based Research
Q&A with Ulrich Broeckel, a leader focused on demonstrating the feasibility and value of preemptive pharmacogenomic screening research.
Watch video on how the FinnGen Research Project is improving the understanding of chronic diseases by using population studies.
Learn how pediatric oncologists are working with and seeking out next-generation sequencing (NGS) data to help drive the future of pediatric cancer care.